(Q33948681)

30 July 2017

The use of erlotinib in daily practice: a study on adherence and patients' experiences (English)

1 reference

30 July 2017

Lonneke Timmers

1

1 reference

30 July 2017

Christel C L M Boons

2

1 reference

30 July 2017

Dirk Mangnus

3

1 reference

30 July 2017

Josee E Moes

4

1 reference

30 July 2017

Eleonora L Swart

5

1 reference

30 July 2017

Epie Boven

6

1 reference

30 July 2017

Egbert F Smit

7

1 reference

30 July 2017

Jacqueline G Hugtenburg

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

30 July 2017

1 reference

30 July 2017

11

1 reference

30 July 2017

284

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-284

30 July 2017

0 references

cites work

Exploring chronic myeloid leukemia patients' reasons for not adhering to the oral anticancer drug imatinib as prescribed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

The missing voice of patients in drug-safety reporting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Patient adherence and persistence with oral anticancer treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Medication compliance and persistence: terminology and definitions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Effect of food on the pharmacokinetics of erlotinib, an orally active epidermal growth factor receptor tyrosine-kinase inhibitor, in healthy individuals

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Beliefs about medicines and self-reported adherence among pharmacy clients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Adherence to therapy with oral antineoplastic agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Patient preferences for oral versus intravenous palliative chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Compliance assessed by the Medication Event Monitoring System

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Adherence with adjuvant hormonal therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

The brief illness perception questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Beliefs about medicines predict refill adherence to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Medication beliefs predict medication adherence in older adults with multiple illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-284

Analysis of costs associated with administration of intravenous single-drug therapies in metastatic breast cancer in a U.S. population

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3146940

Effects of smoking on the pharmacokinetics of erlotinib

29 October 2018

1 reference

12 December 2020

Refill adherence to repeat prescriptions of cancer drugs to ambulatory patients

1 reference

12 December 2020

Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies

1 reference

12 December 2020

Comparing adherence and persistence across 6 chronic medication classes

1 reference

12 December 2020

Treatment compliance in childhood and adolescence

1 reference

12 December 2020

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

1 reference

12 December 2020

Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-11-284

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference